Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2' Modified Nucleoside. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118955591B discloses novel nucleoside monomers reducing off-target effects. Enhance supply chain reliability and cost efficiency in oligonucleotide manufacturing.
Patent CN119219711B reveals a novel cation exchange resin purification method for high-purity nucleoside intermediates, ensuring cost reduction and supply reliability.